Among the large panel of neuroendocrine tumours investigated, differences in GPR68 expression were observed with respect to the localisation and malignancy of the tumour entities, with higher IRS values in tumours of the pancreas, rectum, or gut compared to those from other sites. The gene discussed is GPR68; the disease is neoplasm.